Rongione A J, Kusske A M, Reber H A, Ashley S W, McFadden D W
Department of Surgery, UCLA Medical Center and Sepulveda VA Medical Center, Los Angeles, CA 90024, USA.
J Gastrointest Surg. 1997 Mar-Apr;1(2):159-65; discussion 165-6. doi: 10.1016/s1091-255x(97)80104-7.
Over the past few years, evidence has accumulated that implicates proinflammatory cytokines as the mediators responsible for the escalation of acute pancreatitis into a multisystem disease. It has been shown that the degree of serum cytokine elevation, particularly the macrophage-derived cytokines interleukin-1, interleukin-6, and tumor necrosis factor-alpha, correlates with the severity and outcome of acute pancreatitis. Interleukin-10 is an anti-inflammatory cytokine that inhibits cytokine production from the macrophage. The aim of this study was to determine whether interleukin-10 would decrease both the severity of acute pancreatitis and the level of circulating proinflammatory cytokines. Ninety female mice were divided into three equal groups. Group 1 (controls) received intraperitoneal saline solution. Groups 2 and 3 received intraperitoneal cerulein (50 mg/kg/hr) for 7 hours. In addition, group 3 was given 1500 units of intraperitoneal interleukin-10, beginning 1 hour after the induction of acute pancreatitis and every 3 hours thereafter. Animals were killed at 3-hour intervals. Blood samples were obtained for serum amylase and cytokine determinations (interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha). Pancreata were dissected free and fixed in formalin for blinded histologic scoring. Interleukin-10 reduced the serum levels of interleukin-1beta, interleukin-6, tumor necrosis factor-alpha, and amylase in comparison to untreated animals with pancreatitis (P < 0.05). Pancreatic edema, necrosis, and inflammatory cell infiltrate were also reduced in those animals given interleukin-10 (P <0.05). Histologic score, serum cytokines, and amylase levels are elevated during acute pancreatitis. Interleukin-10 given therapeutically, that is, after the onset of acute pancreatitis, lessened the severity of disease, probably through inhibition of the macrophage. This was associated with a decrease in circulating cytokine levels.
在过去几年中,越来越多的证据表明,促炎细胞因子是急性胰腺炎发展为多系统疾病的介导因素。研究表明,血清细胞因子升高的程度,尤其是巨噬细胞衍生的细胞因子白细胞介素-1、白细胞介素-6和肿瘤坏死因子-α,与急性胰腺炎的严重程度和预后相关。白细胞介素-10是一种抗炎细胞因子,可抑制巨噬细胞产生细胞因子。本研究的目的是确定白细胞介素-10是否能降低急性胰腺炎的严重程度和循环促炎细胞因子的水平。90只雌性小鼠被平均分为三组。第1组(对照组)腹腔注射生理盐水。第2组和第3组腹腔注射雨蛙素(50mg/kg/小时),持续7小时。此外,第3组在急性胰腺炎诱导后1小时开始,此后每3小时腹腔注射1500单位白细胞介素-10。每隔3小时处死动物。采集血样测定血清淀粉酶和细胞因子(白细胞介素-1β、白细胞介素-6和肿瘤坏死因子-α)。将胰腺分离出来,用福尔马林固定,进行盲法组织学评分。与未治疗的胰腺炎动物相比,白细胞介素-10降低了白细胞介素-1β、白细胞介素-6、肿瘤坏死因子-α和淀粉酶的血清水平(P<0.05)。给予白细胞介素-10的动物胰腺水肿、坏死和炎症细胞浸润也减少(P<0.05)。急性胰腺炎期间组织学评分、血清细胞因子和淀粉酶水平升高。治疗性给予白细胞介素-10,即在急性胰腺炎发作后给予,可能通过抑制巨噬细胞减轻了疾病的严重程度。这与循环细胞因子水平的降低有关。